8-K 1 s105191.txt CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 - - - - - - - - - - - FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 May 2, 2003 Date of Report (Date of Earliest Event Reported) GENELABS TECHNOLOGIES, INC. (Exact Name of Registrant as Specified in its Charter) 0-19222 94-3010150 (Commission File Number) (IRS Employer Identification No.) 505 Penobscot Drive Redwood City, California 94063 (Address of Principal Executive Offices) (Zip Code) (650) 369-9500 (Registrant's Telephone Number, including Area Code) Item 5. Other Events On May 2, 2003, Genelabs Technologies, Inc. ("Genelabs") issued a press release announcing it had completed the sale of 8.1 million shares of its common stock to institutional and accredited investors (the "Purchasers") at a price of $1.00 per share, for gross proceeds of $8.1 million. Genelabs also issued warrants to the Purchasers for the purchase of an additional 2.43 million shares of Genelabs' common stock at an exercise price of $1.50 per share in connection with the sale. Item 7. Exhibits EXHIBIT NO. DESCRIPTION 10.1 Securities Purchase Agreement, by and among Genelabs and the Purchasers dated as of May 2, 2003. 99.1 Press Release dated May 2, 2003. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunder duly authorized. Dated: May 5, 2003 GENELABS TECHNOLOGIES, INC. By: /s/ Heather Criss Keller ----------------------------------------- Name: Heather Criss Keller Title: Vice President, General Counsel EXHIBIT INDEX EXHIBIT NO. DESCRIPTION 10.1 Securities Purchase Agreement, by and among Genelabs and the Purchasers dated as of May 2, 2003. 99.1 Press Release dated May 2, 2003.